These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30805726)

  • 21. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
    Ozkaynak MF; Krailo M; Chen Z; Feusner J
    Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia.
    Rosa RG; Goldani LZ
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3799-803. PubMed ID: 24752269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.
    Koenig C; Schneider C; Morgan JE; Ammann RA; Sung L; Phillips B
    Support Care Cancer; 2020 Mar; 28(3):1369-1383. PubMed ID: 31264188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving Antibiotic Timing in Febrile Neutropenia for Pediatric Oncology Patients with a Central Line.
    Roseland J
    J Pediatr Oncol Nurs; 2021; 38(3):185-189. PubMed ID: 33616449
    [No Abstract]   [Full Text] [Related]  

  • 25. Hospital mortality rate and length of stay in patients admitted at night to the intensive care unit.
    Morales IJ; Peters SG; Afessa B
    Crit Care Med; 2003 Mar; 31(3):858-63. PubMed ID: 12626997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
    Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
    Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of ED and direct admission care of cancer patients with febrile neutropenia.
    Owolabi DK; Rowland R; King L; Miller R; Hegde GG; Shang J; Lister J; Venkat A
    Am J Emerg Med; 2015 Jul; 33(7):966-9. PubMed ID: 25959844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia.
    Ben-Chetrit E; Eldaim MA; Bar-Meir M; Dodin M; Katz DE
    Int J Antimicrob Agents; 2019 Apr; 53(4):423-428. PubMed ID: 30572008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of an emergency department febrile neutropenia intervention protocol with time to initial antibiotic treatment.
    Seltzer JA; Frankfurt O; Kyriacou DN
    Acad Emerg Med; 2022 Jan; 29(1):73-82. PubMed ID: 34245642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Febrile Neutropenia: Decreasing Time to Antibiotic Administration in a Community Hospital Emergency Department.
    Bruce SD
    Clin J Oncol Nurs; 2021 Feb; 25(1):23-26. PubMed ID: 33480869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center.
    Nguyen M; Jacobson T; Torres J; Wann A
    Cancer Rep (Hoboken); 2021 Jun; 4(3):e1345. PubMed ID: 33635593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of Gram-negative resistance.
    Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
    Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial.
    Lima SS; Nobre V; de Castro Romanelli RM; Clemente WT; da Silva Bittencourt HN; Melo AC; Salomão LC; Serufo JC
    Ann Hematol; 2016 Jun; 95(7):1169-76. PubMed ID: 27118539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
    Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Post chemoterapy febrile neutropenia. Length of stay and experience in our population].
    Pérez-Heras Í; Raynero-Mellado RC; Díaz-Merchán R; Domínguez-Pinilla N
    An Pediatr (Engl Ed); 2020 Mar; 92(3):141-146. PubMed ID: 31239190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.
    van Vught LA; Klein Klouwenberg PM; Spitoni C; Scicluna BP; Wiewel MA; Horn J; Schultz MJ; Nürnberg P; Bonten MJ; Cremer OL; van der Poll T;
    JAMA; 2016 Apr; 315(14):1469-79. PubMed ID: 26975785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care.
    Elting LS; Rubenstein EB; Rolston K; Cantor SB; Martin CG; Kurtin D; Rodriguez S; Lam T; Kanesan K; Bodey G
    J Clin Oncol; 2000 Nov; 18(21):3699-706. PubMed ID: 11054443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Fever Advisory Cards (FACs) as an Initiative to Improve Febrile Neutropenia Management in a Regional Cancer Center Emergency Department.
    Kapil P; MacMillan M; Carvalho M; Lymburner P; Fung R; Almeida B; Van Dorn L; Enright K
    J Oncol Pract; 2016 Sep; 12(9):e858-63. PubMed ID: 27486160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.